Investor's Business Daily on MSN
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer TreatmentJohnson & JohnsonJNJ said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics, adding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback